| Name | Title | Contact Details |
|---|
Consumers Energy is a Jackson, MI-based company in the Software and Internet sector.
Model N is the leading provider of Revenue Management and analytics solutions for Life Sciences and High Tech manufacturers. Over 40,000 users across 60 countries, ranging from the Fortune 500 to emerging businesses, use Model N`s business process and analytics solutions delivered in the Cloud or on-premise to align and improve the revenue management process and to gain actionable insights and drive strategic decisions across marketing, sales, and finance.
Paperless Parts is a Boston-based Series B SaaS company backed by OpenView that is leading the digital transformation for custom part manufacturers. Our cloud-based software helps manufacturers increase revenue and win more business. Paperless Parts` patented technology and proprietary geometry engine unlocks hidden insights that enable job shop manufacturers to modernize and grow their business. Paperless Parts integrates with your ERP system to level up the way you quote and communicate with customers by rapidly pinpointing manufacturability issues, creating quotes, and processing orders for additive manufacturing, sheet-metal fabrication, and CNC machining production processes. Our experienced team has backgrounds in industries like manufacturing, mechanical engineering, software, national defense, and more.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Drive Digital Adoption, Knowledge Retention and Productivity with the only Universal Contextual Guidance tool that works with all of your applications.